The Cancer Research Institute and The Lustgarten Foundation are excited to announce a new partnership, focused exclusively on supporting pancreatic cancer immunotherapy research. – Cancer Research Institute (CRI)

Quoting Cancer Research Institute (CRI) on LinkedIn:

“The Cancer Research Institute and The Lustgarten Foundation are excited to announce a new partnership, focused exclusively on supporting pancreatic cancer immunotherapy research. INSPIRE (Integrated Network for Supporting Pancreatic Cancer Immunotherapy Research Efforts) will encompass the established and ongoing adaptive platform trial, REVOLUTION, evaluating first-line chemo-immunotherapy treatment combinations for patients with metastatic pancreatic adenocarcinoma, and will also expand into new areas of pancreatic immunotherapy research. This next wave in immunotherapy research reflects a shared commitment to transforming pancreatic cancer into a curable disease. Discover: here.”

Source: Cancer Research Institute (CRI)/LinkedIn